Replies to post #179414 on Biotech Values

[DewDiligence]

ENTA’s JMP webcast today had no info that wasn’t discussed on the WF webcast last week; it can safely be skipped.

[DewDiligence]

NVS opens DDI trial of ENTA’s EDP-239 + Alisporvir in healthy volunteers:

http://clinicaltrials.gov/ct2/show/NCT02173574

If the DDI trial proceeds without a hitch, NVS will follow with a phase-2b study of the drug combination in HCV patients. at which time ENTA will earn a $15M milestone payment from NVS.

Related info: #msg-103400913.

(H/t @lomu_j re trial opening.)